100 related articles for article (PubMed ID: 9606960)
21. Involvement of alcohol dehydrogenase, short-chain dehydrogenase/reductase, aldehyde dehydrogenase, and cytochrome P450 in the control of retinoid signaling by activation of retinoic acid synthesis.
Duester G
Biochemistry; 1996 Sep; 35(38):12221-7. PubMed ID: 8823154
[TBL] [Abstract][Full Text] [Related]
22. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline.
Murray M
Mol Pharmacol; 1992 Nov; 42(5):931-8. PubMed ID: 1435757
[TBL] [Abstract][Full Text] [Related]
23. Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5.
John GH; Hasler JA; He YA; Halpert JR
Arch Biochem Biophys; 1994 Nov; 314(2):367-75. PubMed ID: 7979377
[TBL] [Abstract][Full Text] [Related]
24. N,N',N''-triethylenethiophosphoramide (thio-TEPA) oxygenation by constitutive hepatic P450 enzymes and modulation of drug metabolism and clearance in vivo by P450-inducing agents.
Ng SF; Waxman DJ
Cancer Res; 1991 May; 51(9):2340-5. PubMed ID: 1707751
[TBL] [Abstract][Full Text] [Related]
25. Characterization of rat small intestinal cytochrome P450 composition and inducibility.
Zhang QY; Wikoff J; Dunbar D; Kaminsky L
Drug Metab Dispos; 1996 Mar; 24(3):322-8. PubMed ID: 8820423
[TBL] [Abstract][Full Text] [Related]
26. Glucuronidation of all-trans-retinoic acid in liposomal membranes.
Salyers KL; Cullum ME; Zile MH
Biochim Biophys Acta; 1993 Nov; 1152(2):328-34. PubMed ID: 8218334
[TBL] [Abstract][Full Text] [Related]
27. Inhibition and inactivation of constitutive cytochromes P450 in rat liver by parathion.
Butler AM; Murray M
Mol Pharmacol; 1993 Jun; 43(6):902-8. PubMed ID: 8316222
[TBL] [Abstract][Full Text] [Related]
28. Characterization of xenobiotic metabolizing enzymes in bovine small intestinal mucosa.
Virkel G; Carletti M; Cantiello M; Della Donna L; Gardini G; Girolami F; Nebbia C
J Vet Pharmacol Ther; 2010 Jun; 33(3):295-303. PubMed ID: 20557447
[TBL] [Abstract][Full Text] [Related]
29. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
Teiber JF; Hollenberg PF
Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
[TBL] [Abstract][Full Text] [Related]
30. Oxidation of tolualdehydes to toluic acids catalyzed by cytochrome P450-dependent aldehyde oxygenase in the mouse liver.
Watanabe K; Matsunaga T; Yamamoto I; Yashimura H
Drug Metab Dispos; 1995 Feb; 23(2):261-5. PubMed ID: 7736922
[TBL] [Abstract][Full Text] [Related]
31. The rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway: characterization and significance.
Zeldin DC; Plitman JD; Kobayashi J; Miller RF; Snapper JR; Falck JR; Szarek JL; Philpot RM; Capdevila JH
J Clin Invest; 1995 May; 95(5):2150-60. PubMed ID: 7738183
[TBL] [Abstract][Full Text] [Related]
32. Rat small intestinal cytochromes P450 probed by warfarin metabolism.
Fasco MJ; Silkworth JB; Dunbar DA; Kaminsky LS
Mol Pharmacol; 1993 Feb; 43(2):226-33. PubMed ID: 8429825
[TBL] [Abstract][Full Text] [Related]
33. 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors.
Tsukada M; Schröder M; Roos TC; Chandraratna RA; Reichert U; Merk HF; Orfanos CE; Zouboulis CC
J Invest Dermatol; 2000 Aug; 115(2):321-7. PubMed ID: 10951254
[TBL] [Abstract][Full Text] [Related]
34. 13-cis-retinoic acid metabolism in vivo. The major tissue metabolites in the rat have the all-trans configuration.
McCormick AM; Kroll KD; Napoli JL
Biochemistry; 1983 Aug; 22(16):3933-40. PubMed ID: 6577913
[TBL] [Abstract][Full Text] [Related]
35. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
Amato G; Longo V; Mazzaccaro A; Gervasi PG
Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
[TBL] [Abstract][Full Text] [Related]
36. CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization, and potential functional significance.
Zeldin DC; Foley J; Goldsworthy SM; Cook ME; Boyle JE; Ma J; Moomaw CR; Tomer KB; Steenbergen C; Wu S
Mol Pharmacol; 1997 Jun; 51(6):931-43. PubMed ID: 9187259
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the n-alkane and fatty acid hydroxylating cytochrome P450 forms 52A3 and 52A4.
Scheller U; Zimmer T; Kärgel E; Schunck WH
Arch Biochem Biophys; 1996 Apr; 328(2):245-54. PubMed ID: 8645001
[TBL] [Abstract][Full Text] [Related]
38. Metabolism of N-nitroso-2,6-dimethylmorpholine by isozymes of rabbit liver microsomal cytochrome P-450.
Kokkinakis DM; Koop DR; Scarpelli DG; Coon MJ; Hollenberg PF
Cancer Res; 1985 Feb; 45(2):619-24. PubMed ID: 3967237
[TBL] [Abstract][Full Text] [Related]
39. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
[TBL] [Abstract][Full Text] [Related]
40. Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8.
Rahman A; Korzekwa KR; Grogan J; Gonzalez FJ; Harris JW
Cancer Res; 1994 Nov; 54(21):5543-6. PubMed ID: 7923194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
